ITGB7

ITGB7 (integrin β7) is a transcriptionally regulated adhesion molecule whose expression is controlled by distinct signaling inputs in immune and epithelial contexts (PMID:9683663, PMID:32929153). TGF-β1 induces β7 integrin transcription through two defined promoter response regions (TGFBRR1 and TGFBRR2) that recruit inducible nuclear protein complexes in a tyrosine-phosphorylation-dependent manner (PMID:9683663). In a separate regulatory axis, NRF2 binds directly to an antioxidant response element in the ITGB7 promoter downstream of ROS/TRIM2 signaling to activate ITGB7 transcription, and the resulting ITGB7 protein engages the focal adhesion kinase (FAK) pathway to promote pancreatic cancer progression (PMID:32929153). ITGB7 marks spatially distinct dendritic cell subsets in the pregnant uterus, where ITGA4/ITGB7+ and ITGAE/ITGB7+ cells occupy separate microdomains and vascular-zone subsets make direct contact with uterine natural killer cells (PMID:18562709). Beyond these transcriptional and adhesion-signaling roles, the structural details of its heterodimer-mediated function are not characterized in the available corpus.

1. 1998 Medium

   Established how β7 integrin transcription is induced, identifying the TGF-β1-responsive promoter architecture that links a cytokine signal to integrin expression.

   Evidence Promoter deletion analysis, reporter assays, DNase I hypersensitivity mapping, EMSA, and genistein inhibition in the β7 promoter

   PMID:9683663

   Open questions at the time

   • Identity of the bound protein complexes not determined
   • The specific tyrosine kinase mediating the phosphorylation-dependent step not identified
   • Does not connect transcriptional induction to downstream adhesion function
2. 2008 Medium

   Defined ITGB7 as a marker distinguishing functionally and spatially separate dendritic cell subsets at the maternal-fetal interface, implying distinct homing roles for its α4 and αE pairings.

   Evidence Multiparameter flow cytometry and confocal microscopy of pregnant mouse uterus

   PMID:18562709

   Open questions at the time

   • The functional consequence of DC–uterine NK cell contact not demonstrated
   • Whether ITGB7 itself mediates the microdomain localization not tested
   • No loss-of-function validation
3. 2020 Medium

   Connected a second transcriptional input (ROS/TRIM2/NRF2) to ITGB7 and established a downstream effector pathway (FAK) driving cancer progression, expanding ITGB7 beyond immune homing into tumor biology.

   Evidence NRF2 ChIP/promoter binding at ARE, ROS scavenger and siRNA manipulation, rescue and in vivo tumorigenicity assays in pancreatic cancer

   PMID:32929153

   Open questions at the time

   • Mechanism by which ITGB7 activates FAK not resolved
   • Whether the αE/α4 partner is required for the oncogenic role not addressed
   • Generalizability beyond pancreatic cancer untested
4. 2019 Low

   Linked ITGB7 to a glycolytic/proliferative program in cervical cancer via a putative ITGB7/C/EBPβ axis modulated by HPV16 L2.

   Evidence Gene-chip, RT-PCR, Western blot, metabolic assays, and in vivo model in cervical cancer cells

   PMID:31819523

   Open questions at the time

   • Correlative readouts without direct ITGB7–C/EBPβ binding or reconstitution
   • No demonstration that ITGB7 directly regulates the glycolytic enzymes
   • Single lab, unconfirmed
5. 2024 Low

   Implicated host ITGB7 as a facilitator of HPV infection of epithelial cells in the context of Trichomonas vaginalis co-infection.

   Evidence siRNA knockdown of ITGB7 in HaCaT cells with HPV infection quantification (preprint)

   Open questions at the time

   • Single knockdown among 12 screened genes; mechanism uncharacterized
   • Preprint, not peer-reviewed
   • No reciprocal or rescue validation

• How the ITGB7 heterodimer transduces adhesion signals at the molecular level, and whether its diverse transcriptional regulators converge on a shared functional output, remains unresolved.
• No structural model of ITGB7 heterodimers in the corpus
• Ligand engagement and inside-out/outside-in signaling not characterized here
• Mechanistic link between transcriptional induction and FAK activation not established